Quantcast

Latest Nerve Stories

2014-06-18 23:11:38

Expanded outcomes data from the Ranger® Registry to be presented Alachua, FL (PRWEB) June 18, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, today announced the acceptance of two clinical presentations on the use of Avance® Nerve Graft and a scientific presentation on the use of coaptation aids in nerve repair at the 29th Congress of the Federation of European Societies for Surgery of the Hand (FESSH), June...

2014-06-09 23:07:46

Nerve Repair Company AXGN to participate in investor conference in New York Alachua, FL (PRWEB) June 09, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is scheduled to present at the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 12:30pm (ET) at the Westin New York Grand Central. A live webcast and subsequent archived replay of the Company’s presentation may be accessed...

2014-06-04 23:10:04

$1.9 Million in Grant funding will explore application of novel stem cells and development of branched grafts for complex nerve repair Alachua, FL (PRWEB) June 04, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it would share in the award of two Department of Defense Grants totaling approximately $1.9 million with Brigham and Women’s Hospital in Boston (BWH). The grants, awarded to Principal...

2014-05-13 15:21:34

Elsevier Health Sciences Corneal nerve fiber assessment proposed for managing patients with HIV-induced peripheral neuropathy, according to The American Journal of Pathology Corneal nerve fiber assessment has great potential as a tool to diagnose and monitor peripheral neuropathy induced by HIV, say scientists at the Johns Hopkins University School of Medicine. The results of their study are published in The American Journal of Pathology. Although corneal nerve assessments have shown...

2014-05-05 23:08:17

AxoGen selected as one of 20 presenting companies Alachua, FL (PRWEB) May 05, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion U.S. peripheral nerve repair market, announced today that it has been selected from a record number of applicants as a presenting company at the 2014 Conference of the Southeastern Medical Device Association (SEMDA). The eighth annual SEMDA Conference, “Thriving During Healthcare Reform,” will be held May 7-8,...

2014-04-28 23:08:35

Company to feature portfolio of products for peripheral nerve repair, protection and regeneration at ACOMS Annual Meeting Alachua, FL (PRWEB) April 28, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it will be highlighting its products at the American College of Oral and Maxillofacial (ACOMS) 35th Annual Scientific Conference and Exhibition, April 27-30 in Las Vegas, Nevada. AxoGen is exhibiting its full...

2014-04-22 10:40:12

New research published today out of the University of Calgary's Hotchkiss Brain Institute (HBI) uncovers a mechanism to promote growth in damaged nerve cells as a means to restore connections after injury. Dr. Doug Zochodne and his team have discovered a key molecule that directly regulates nerve cell growth in the damaged nervous system. His study was published in the prestigious journal Nature Communications, with lead authors Drs. Kim Christie and Anand Krishnan. "We made the surprising...

2014-04-01 14:58:41

A new discovery suggests it could one day be possible to chemically reprogram and repair damaged nerves after spinal cord injury or brain trauma. Researchers from Imperial College London and the Hertie Institute, University of Tuebingen have identified a possible mechanism for re-growing damaged nerve fibres in the central nervous system (CNS). This damage is currently irreparable, often leaving those who suffer spinal cord injury, stroke or brain trauma with serious impairments like loss...

2014-03-12 23:24:47

Supports Growing Interest in Nerve Repair from Orthopedic Surgeons Alachua, FL (PRWEB) March 12, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, is pleased to announce its participation at the American Academy of Orthopedic Surgeons (AAOS) 2014 Annual Meeting, March 11-15, 2014 at the Morial Convention Center in New Orleans, LA, Booth 5818. “Increasing demand for nerve repair product options from orthopedic surgeons makes...

2014-02-12 23:24:21

Nerve repair company to release results and host earnings call Alachua, FL (PRWEB) February 12, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only company completely focused on peripheral nerve repair, will report results for the fourth quarter and full year ended December 31, 2013 on Thursday, March 6, 2014 after the market closes. The Company will host a conference call and webcast for the investment community on Thursday, March 6, 2014 at 4:30 PM ET. Investors within the United States...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related